Homepage

Stories / Discovery

Researcher races to find new treatment for his progressive disease

Ice hockey used to help Tyler Patron combat cystic fibrosis, but he hopes the lab could yield ...

Researcher Edmund Ekuadzi, an expert on the medical properties of plants, examines a specimen gathered in his homeland of Ghana.

Stories / Global Impact

A researcher seeks the roots of plants' healing power

Deep in a forest in the West African country of Ghana, two men are searching for plants that they ...

After being diagnosed with an aggressive form of leukemia, Ilana Massi defied the odds with the help of her friends and family.

Stories / Hope

From nurse to patient: facing an aggressive blood cancer

After being diagnosed with an aggressive form of leukemia, Ilana Massi defied the odds with the help ...

Explore Novartis

About Us

Corporate Responsibility

Research & Development

Clinical Pipeline

Recent Updates

André Mama Fouda, Minister of Public Health of the Republic of Cameroon and Harald Nusser, Head of Novartis Social Business, sign agreement.

Featured / Sep 28

Novartis Access and government of Cameroon sign agreement to fight chronic diseases

Cameroon faces a serious increase in chronic diseases like heart disease, asthma, cancer and diabetes. This agreement complements the government’s ongoing efforts by improving access to affordable medicines and educating patients.

Media Release / Oct 24

Novartis delivered growth on top and bottom line in all divisions in Q3

Novartis to host stakeholder dialogue on ways to improve access to healthcare in lower-income countries

The event will take place on November 21 in ...

Media Release / Sep 28

Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets

View All

We’re adapting virtual reality #gaming tech to help speed up drug discovery https://t.co/MTZCBukkc1 #vr https://t.co/K4QxjLZ1Ao 3 min 21 sec ago

We’re excited to be attending #MSParis2017! Learn more about the world’s largest #MS congress: https://t.co/GNigUe9fqs 1 hour 35 min ago

BREAKING: Our Q3 results are just in, showing growth through a continued focus on R&D https://t.co/4cPTYvbELp… https://t.co/6m917GiTRB 4 hours 22 min ago

Our Business

Novartis focuses its business on three divisions with innovation power and global scale: innovative medicines, eye care and generics.

Learn More